Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Related links
PowerPoint slides
Rights and permissions
About this article
Cite this article
Dawkins, J., Webster, R. The hepatocellular carcinoma market. Nat Rev Drug Discov 18, 13–14 (2019). https://doi.org/10.1038/nrd.2018.146
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2018.146
- Springer Nature Limited
This article is cited by
-
Stratifying ICIs-responsive tumor microenvironment in HCC: from parsing out immune-hypoxic crosstalk to clinically applicable MRI-radiomics models
British Journal of Cancer (2024)
-
Network pharmacological analysis of corosolic acid reveals P4HA2 inhibits hepatocellular carcinoma progression
BMC Complementary Medicine and Therapies (2023)
-
Artemongolins A–K, undescribed germacrane-guaiane sesquiterpenoid dimers from Artemisia mongolica and their antihepatoma activities
Archives of Pharmacal Research (2023)
-
Nonviral mcDNA-mediated bispecific CAR T cells kill tumor cells in an experimental mouse model of hepatocellular carcinoma
BMC Cancer (2022)
-
Preclinical Therapeutic Evaluation of Lenvatinib-Eluting Microspheres for Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma
CardioVascular and Interventional Radiology (2022)